|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Superstring Capital Management LP
✚
|
|
|---|---|
| CRD # | 305743 |
| SEC # | 801-118766 |
| CIK # | 0001931118 |
| AUM | $218.3 M (2025-03-28) |
| Employees | 5 (60% Investors, 0% Brokers) |
| Phone | 212-257-5690 |
| Address | 150 E 52nd St New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0001931118 |
| Sector | Form 13F Holdings | Value ($M) |
|---|---|---|
| Capnia Inc | 7.0 | |
| UNUM Therapeutics Inc | 6.9 | |
| Verona Pharma PLC | 6.5 | |
| Neurocrine Biosciences Inc | 5.1 | |
| Terns Pharmaceuticals Inc | 4.8 | |
| Ultragenyx Pharmaceutical Inc | 4.7 | |
| Zai Lab Ltd | 4.7 | |
| Jazz Pharmaceuticals Inc | 4.7 | |
| Bridgebio Pharma Inc | 4.2 | |
| Desert Gateway Inc | 4.1 | |
| ISIS Pharmaceuticals Inc | 3.9 | |
| Oric Pharmaceuticals Inc | 3.5 | |
| Adventrx Pharmaceuticals Inc | 2.5 | |
| 89bio Inc | 2.1 | |
| Cytokinetics Inc | 2.0 | |
| Bicara Therapeutics Inc | 1.8 | |
| Cabaletta Bio Inc | 1.6 | |
| AVROBIO Inc | 1.6 | |
| Insmed Inc | 1.5 | |
| United Therapeutics Corp | 1.4 | |
| Avidity Biosciences Inc | 1.3 | |
| UroGen Pharma Ltd | 1.2 | |
| Proteon Therapeutics Inc | 1.1 | |
| Zenas Biopharma Inc | 1.1 | |
| Liquidia Corp | 0.9 | |
| Helix Acquisition Corp | 0.8 | |
| Ocular Therapeutix Inc | 0.8 | |
| Inotek Pharmaceuticals Corp | 0.5 | |
| Wave Life Sciences Ltd | 0.5 | |
| Biomea Fusion Inc | 0.5 | Prev | Page 1 | Next |
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| PE | Superstring Private Opportunites Fund I LP | [2022-03-30] | 9.8 | 31.0 |
| HF | Superstring Capital Master Fund LP | [2019-10-18] | 63.6 | 177.1 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 5 | 208.1 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 1 | 10.2 |
| Total | 6 | 218.3 |
| By Discretionary | ||
| Discretionary | 6 | 218.3 |
| Non-Discretionary | 0 | 0.0 |
| Total | 6 | 218.3 |
| By Non-United States Persons | ||
| Non-United States Persons | 74.1 | |
| United States Persons | 144.2 | |
| Total | 6 | 218.3 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Patrick Agemian | 109 | ||
| Martin Lang | 159 | ||
| George Song | 6 | ||
| Superstring Capital Management LP | 4 | ||
| Superstring Capital Fund GP LLC | 3 | ||
| Ting Guo | 3 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001931118] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Corinthian Capital Group LLC
✚
|
NY | 0.2 |
|
Saybrook Fund Advisors LLC
✚
|
CA | 0.2 |
|
Rosenwald Capital Management Inc
✚
|
CA | 0.2 |
|
Proteus LLC
✚
|
IN | 0.2 |
|
Prentice Capital Management LP
✚
|
CT | 0.2 |
|
Zephyr Management LP
✚
|
NY | 0.2 |
|
Ma Asset Management LLC
✚
|
NY | 0.2 |
|
Yost Capital Management LP
✚
|
TX | 0.2 |
|
Gatemore Capital Management LP
✚
|
NY | 0.2 |
|
Merida Capital Holdings LLC
✚
|
NY | 0.2 |